Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
10612studies shown
Showing 6,661-6,672 of 10,612
Drug study icon
CompletedNCT01284517

Lurasidone HCI - A 6-week Phase 3 Study of people with Bipolar I Depression

This study is completed in the United States, in Canada, in Colombia, .... It focuses on depression.

In United States
Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States, Canada, Colombia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01821378

Lurasidone Low-Dose - High-Dose Study Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 75 Years
Countries
United States, Colombia, Romania, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT02046369

Lurasidone Pediatric Bipolar Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Bipolarity, DepressionDrugFrom 10 Years to 17 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01620060

Lurasidone Pediatric Pharmacokinetics Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 6 Years to 17 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Other study type icon
CompletedNCT05204407

Luteolin for People With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
CompletedNCT05105542

M1 Schizophrenia PET Study

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Behavioral study icon
TerminatedNCT03482466

Machine Learning Neurofeedback for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States
PTSDBehavioralFrom 18 Years to 64 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
PTSD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.